Global Cardiac Ablation Market 2017-2021

  • ID: 4225851
  • Report
  • Region: Global
  • 70 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • AblaCor
  • AngioDynamics.
  • Boston Scientific
  • Medtronic
  • St. Jude Medical
  • MORE
About Cardiac Ablation

Cardiac ablation is an endovascular procedure that helps to treat an irregular heart rhythm and is performed with the help of an ablation device and catheter. These products use radio frequency (RF) as an energy source to destroy unhealthy heart tissues. Ablation catheters remove faulty electrical pathways from the heart, thereby reducing the risk of ventricular fibrillation and sudden cardiac arrest. Cardiac arrhythmias are characterized by an abnormal heart rhythm, which is lower than 60 beats per minute, more than 100 beats per minute, or irregular. The improper functioning of the electrical systems regulating the heart can cause arrhythmia. Arrhythmias are of various types, including atrial fibrillation, atrial flutter, and atrioventricular nodal re-entrant tachycardia.

The analysts forecast the global cardiac ablation market to grow at a CAGR of 7.6% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global cardiac ablation market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

The report, Global Cardiac Ablation Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Boston Scientific
- Medtronic
- St. Jude Medical

Other prominent vendors
- AblaCor
- Advanced Cardiac Therapeutics
- AngioDynamics
- APT Medical
- AtriCure
- BIOTRONIK
- Biosense Webster
- CardioFocus
- DVx
- Galgo Medical
- Hansen Medical
- Imricor
- Lepu Medical
- Melys AFS
- MicroPor Scientific
- Osypka Medical
- PLC Medical Systems
- Spectranetics
- VytronUS

Market drivers
- Rising incidences of cardiac diseases and growth of insurance providers.
- For a full, detailed list, view the full report

Market challenges
- Complications associated with cardiac ablation and stringent regulatory framework.
- For a full, detailed list, view the full report

Market trends
- Transforming marketing and sales strategies for cardiac ablation.
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AblaCor
  • AngioDynamics.
  • Boston Scientific
  • Medtronic
  • St. Jude Medical
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Key market highlights
PART 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 06: Market segmentation by product
  • Global cardiac ablation devices market
  • Cardiac ablation catheters market
PART 07: Market segmentation by procedures
  • Atrial fibrillation ablation
  • Supraventricular tachycardia ablation
  • Ventricular tachycardia ablation
PART 08: Market segmentation by end-user
  • Hospitals and clinics
  • ASCs
PART 09: Geographical segmentation
  • Cardiac ablation market in Americas
  • Cardiac ablation market in EMEA
  • Cardiac ablation market in APAC
PART 10: Decision framework

PART 11: Drivers and challenges
  • Market drivers
  • Impact of drivers on key customer segments
  • Market challenges
  • Impact of challenges on key customer segments
PART 12: Market trends
  • Transforming marketing and sales strategies for cardiac ablation
  • Emergence of digital cath labs in hospitals
  • Integration of robotic cardiac catheter system and hybrid operating room equipment
PART 13: Vendor landscape
  • Competitive landscape
PART 14: Key vendor analysis
  • Boston Scientific
  • Medtronic
  • St. Jude Medical
  • Other prominent vendors
PART 15: Appendix
  • List of abbreviations
List of Exhibits
Exhibit 01: Global cardiac ablation market overview 2016
Exhibit 02: Global cardiac ablation market 2016-2021 ($ billions)
Exhibit 03: Five forces analysis
Exhibit 04: Global cardiac ablation market by product 2016 and 2021 ($ billions)
Exhibit 05: Buying criteria of cardiac ablation products 2016 and 2021
Exhibit 06: Market overview: Global cardiac ablation devices market
Exhibit 07: Global cardiac ablation devices market 2016-2021 ($ billions)
Exhibit 08: Market overview: Cardiac ablation catheters market
Exhibit 09: Global cardiac ablation catheters market 2016-2021 ($ billions)
Exhibit 10: Global cardiac ablation market by procedures in 2016
Exhibit 11: Global cardiac ablation market by end-user in 2016
Exhibit 12: Global cardiac ablation market by geography 2016 and 2021 ($ billions)
Exhibit 13: An overview of cardiac diseases in US
Exhibit 14: Market overview: Cardiac ablation market in Americas
Exhibit 15: Cardiac ablation market in Americas 2016-2021 ($ billions)
Exhibit 16: Cardiac ablation market in Americas: Market analysis by country
Exhibit 17: Market overview: Cardiac ablation market in US
Exhibit 18: Impact of accountable care organizations (ACO) and ACA on cardiac ablation
Exhibit 19: Market overview: Cardiac ablation market in Europe
Exhibit 20: Cardiac ablation market in EMEA 2016-2021 ($ billions)
Exhibit 21: Cardiac ablation market in EMEA: Market analysis by country
Exhibit 22: Market overview: Cardiac ablation market in UK
Exhibit 23: Market overview: Cardiac ablation market in APAC
Exhibit 24: Cardiac ablation market in APAC 2016-2021 ($ billions)
Exhibit 25: Cardiac ablation market in APAC: Market analysis by country
Exhibit 26: Market overview: Cardiac ablation market in South Korea
Exhibit 27: Increasing number of CVDs (hypertension) versus number of Medicare providers in US 2011-2013
Exhibit 28: Clinical studies for cardiac ablation: Companies and CROs
Exhibit 29: Impact of drivers
Exhibit 30: Cost of cardiac ablation products
Exhibit 31: Research studies: Complications associated with cardiac ablation
Exhibit 32: Product recalls 2014-2015
Exhibit 33: Impact of challenges
Exhibit 34: Marketing and sales strategies by large and small companies
Exhibit 35: Competitive structure analysis of global cardiac ablation market 2016
Exhibit 36: Competitive landscape of global cardiac ablation market 2016
Exhibit 37: Global cardiac ablation market: Market penetration of companies 2016
Exhibit 38: Strategies of large and small companies in global cardiac ablation market
Exhibit 39: Boston Scientific: Strength assessment
Exhibit 40: Boston Scientific: Strategy assessment
Exhibit 41: Boston Scientific: Opportunity assessment
Exhibit 42: Medtronic: Strength assessment
Exhibit 43: Medtronic: Strategy assessment
Exhibit 44: Medtronic: Opportunity assessment
Exhibit 45: St. Jude Medical: Strength assessment
Exhibit 46: St. Jude Medical: Strategy assessment
Exhibit 47: St. Jude Medical: Opportunity assessment
Exhibit 48: Other prominent vendors in global cardiac ablation market
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • AblaCor
  • AngioDynamics.
  • Boston Scientific
  • Medtronic
  • St. Jude Medical
  • MORE
New Report Released: – Global Cardiac Ablation Market 2017-2021

The author of the report recognizes the following companies as the key players in the global cardiac ablation market: Boston Scientific, Medtronic, and St. Jude Medical.

Other Prominent Vendors in the market are: AblaCor, Advanced Cardiac Therapeutics, and AngioDynamics.

Commenting on the report, an analyst from the research team said: “One trend in market is emergence of digital cath labs in hospitals. Cath labs or cardiac catheterization laboratories in hospitals conduct both diagnostic and therapeutic procedures. These laboratories are used to conduct normal procedures such as the monitoring of blood flow and heart pressure. Advances in catheterization technology such as robot-assisted catheterization for cardiac catheterization have advanced the digital imaging system.”

According to the report, one driver in market is growing focus on clinical trials. Vendors are using advanced technologies to develop innovative ablation catheters. They invest in R&D to develop cost-effective and efficient devices and lower manufacturing costs. Many of these devices are awaiting approval across different countries. To prove the safety and efficacy profiles of their products, vendors conduct clinical trials. These studies will help vendors fulfill the regulatory requirements for product approvals. Positive or negative results of long-term follow-ups from clinical trials will also affect market growth. For instance, positive results of St. Jude Medical’s clinical trial for Flexibility ablation catheter, an irrigated ablation catheter with a flexible tip, led the product to receive the US FDA approval in January 2015.

Further, the report states that one challenges in market is lack of reimbursement in APAC and Africa. The cost of procedures and technology play a significant role in determining their adoption. While reimbursement covers ablation catheter procedures in countries such as Germany, France, and the UK, many countries do not provide reimbursement for physicians and hospitals. In APAC, only some countries such as Japan provide partial or fixed reimbursements for devices and procedures. The restrictive reimbursement environment in China, India, and African countries such as South Africa is limiting the adoption of cardiac ablation procedures, which has impacted the sales of cardiac ablation devices and catheters negatively.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Boston Scientific
  • Medtronic
  • St. Jude Medical
  • AblaCor
  • Advanced Cardiac Therapeutics
  • AngioDynamics.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll